|
Volumn 24, Issue SUPPL. 1, 1997, Pages 239-249
|
Pre- and/or post-operative immunochemotherapy for advanced digestive cancer
a a a |
Author keywords
5 FU lentinan therapy; Digestive cancer; Endogenous LAK therapy; Immunochemotherapy; Low dose CDDP; OK 432; Postoperative adjuvant therapy; PSK
|
Indexed keywords
BIOLOGICAL RESPONSE MODIFIER;
CISPLATIN;
FLUOROURACIL;
LENTINAN;
MITOMYCIN C;
PICIBANIL;
POLYSACCHARIDE;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIGESTIVE SYSTEM CANCER;
DOSE RESPONSE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
IMMUNOTHERAPY;
KILLER CELLS, LYMPHOKINE-ACTIVATED;
LENTINAN;
LIVER NEOPLASMS;
POSTOPERATIVE CARE;
PROTEOGLYCANS;
STOMACH NEOPLASMS;
SURVIVAL RATE;
|
EID: 0030884442
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (14)
|